Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DEXTROSE 5 SODIUM CHLORIDE 0 2 AND POTASSIUM CHLORIDE 0 3 IN PLASTIC CONTAINER versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5%, SODIUM CHLORIDE 0.2% AND POTASSIUM CHLORIDE 0.3% IN PLASTIC CONTAINER vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose provides caloric support and corrects hypoglycemia by increasing blood glucose levels. Sodium chloride maintains osmotic pressure and fluid balance. Potassium chloride replaces potassium deficits and maintains electrolyte homeostasis.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
IV infusion; rate and volume determined by fluid, electrolyte, and caloric requirements. Typical adult: 100-200 mL/hour, not to exceed 25 g dextrose/hour (500 mL/hour of D5) and 10 mEq potassium/hour. Total daily dose: 1-3 L/day.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Not applicable as a combined solution; dextrose half-life ~1-2 hours (plasma glucose clearance); potassium half-life depends on distribution and renal function (approx. 1-2 hours for serum K correction); sodium and chloride have no defined half-life.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Renal (glucose and ions are handled by the kidneys; potassium excreted via urine; sodium and chloride reabsorbed or excreted as needed; dextrose metabolized to CO2 and water; <5% unchanged glucose excreted in urine if normoglycemic)
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte